US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids

Overview of attention for article published in Drugs, December 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 888 followers.

...pros y contras y perspectiva europea http://t.co/XsKO0bti Drugs

...pros y contras y perspectiva europea http://t.co/XsKO0bti Drugs

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.